Investors / United States / Autism Impact Fund
Autism Impact Fund
Venture capital · Orlando, FL, United States · North America
Autism Impact Fund is a venture and growth capital investment firm focused on behavioral health, mental health, autism, and complex chronic conditions. It invests in early- and growth-stage companies and works with founders to develop sustainable business models, using relationships across healthcare, research, advocacy, and policy.
Invests inHealthcare & Biotech
In its own wordsbehavioral healthmental healthautismneurodevelopmenthealthcaredigital health
Your fit with Autism Impact Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAutism Impact Fund lists 16 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%), AI & Machine Learning (6%) and Education (6%). 100% of its companies are based in United States. It invests most often alongside Difference Partners, .406 Ventures and CVS Health Ventures.
Counts come from funding rounds that name Autism Impact Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Autism Impact Fund's whole history. Rounds on record name 2 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 50% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 42th | 16 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 68th | 6% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Difference Partners | 3 |
| .406 Ventures | 2 |
| CVS Health Ventures | 2 |
| F-Prime Capital | 2 |
| Optum Ventures | 2 |
| 8VC | 1 |
| ARCH Venture Partners | 1 |
| AlbionVC | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers16100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| AI & Machine Learning | 6% | 18% |
| Education | 6% | 7% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Difference Partners
Compare Autism Impact Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Autism Impact Fund| Date | Company | Stage |
|---|---|---|
| 19 Aug 2026 | Series C+ | |
| 17 Sept 2025 | Series B |
Round details for Autism Impact Fund
Amounts, full round histories and every co-investor in Autism Impact Fund's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Bluebird Kids Health provides pediatric care services, including newborn care, well-checks, and sick visits. | Healthcare & Biotech | Portfolio page | ||
| Cortica specializes in evidence-based ABA therapy, speech therapy, occupational therapy, and more for children with autism spectrum disorder (ASD). | Healthcare & Biotech | Portfolio page | ||
| Eleplan provides an operating system for family caregivers to manage care records, routines, and teams in one plan | Healthcare & Biotech | Portfolio page | ||
| Floreo develops virtual reality therapy for neurodiverse individuals to practice communication and social skills | Healthcare & Biotech | Portfolio page | ||
| Healios provides online autism, ADHD, and mental health services. | Healthcare & Biotech | Portfolio page | ||
| The company provides primary care services to seniors in rural North Carolina. | Healthcare & Biotech | Aug 2026Series C+ | Page + round | |
| Imagine Pediatrics provides 24/7 virtual and in-home care for children with special health care needs. | Healthcare & Biotech | Sept 2025Series B | Funding round | |
| Jaguar Gene Therapy accelerates breakthroughs in gene therapy for patients suffering from severe genetic diseases. | Healthcare & Biotech | Portfolio page | ||
| Joshin connects employees, families, caregivers, and managers with expert coaches, therapists, and service providers, offering continuous support and care for all aspects of life. | Healthcare & Biotech | Portfolio page | ||
| Camber provides revenue cycle management billing software for specialty care healthcare providers. | Healthcare & Biotech | Portfolio page | ||
| MARAbio has developed precision technology to accurately predict the likelihood of Maternal Autoantibody Related Autism (MARA) in a child through a simple blood test in the mother | Healthcare & Biotech | Portfolio page | ||
| SpectrumAi helps BCBAs embrace cutting-edge tools while maintaining a human connection by combining data analytics, AI technology, and traditional methodologies | Healthcare & Biotech | Portfolio page | ||
| Suggestic designs, builds, and operates custom enterprise AI systems for regulated and consumer-facing businesses | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| Unison Therapy Services provides behavior therapy and other services to schools and families | Healthcare & BiotechEducation | Portfolio page | ||
| Yamo Pharmaceuticals is developing L1-79, an investigational oral drug for the core social-interaction symptoms of autism, and is preparing a Phase 3 study. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- autismimpact.fund
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 17 Sept 2025
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Autism Impact Fund's profile as data
Pull Autism Impact Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/autismimpact.fund
# also
GET /v1/firms/autismimpact.fund/portfolio
GET /v1/firms/autismimpact.fund/coinvestors
GET /v1/firms/autismimpact.fund/news